| Phenotypic clustering in MPZ mutations ME Shy, A Jáni, K Krajewski, M Grandis, RA Lewis, J Li, RR Shy, ... Brain 127 (2), 371-384, 2004 | 334 | 2004 |
| Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial IN van Schaik, V Bril, N van Geloven, HP Hartung, RA Lewis, G Sobue, ... The Lancet Neurology 17 (1), 35-46, 2018 | 261 | 2018 |
| Skin biopsies in myelin-related neuropathies: bringing molecular pathology to the bedside J Li, Y Bai, K Ghandour, P Qin, M Grandis, A Trostinskaia, E Ianakova, ... Brain 128 (5), 1168-1177, 2005 | 146 | 2005 |
| Intracranial pressure monitoring in patients with acute brain injury in the intensive care unit (SYNAPSE-ICU): an international, prospective observational cohort study C Robba, F Graziano, P Rebora, F Elli, C Giussani, M Oddo, G Meyfroidt, ... The Lancet Neurology 20 (7), 548-558, 2021 | 137 | 2021 |
| Nusinersen safety and effects on motor function in adult spinal muscular atrophy type 2 and 3 L Maggi, L Bello, S Bonanno, A Govoni, C Caponnetto, L Passamano, ... Journal of Neurology, Neurosurgery & Psychiatry 91 (11), 1166-1174, 2020 | 119 | 2020 |
| Predictors of response to rituximab in patients with neuropathy and anti–myelin associated glycoprotein immunoglobulin M L Benedetti, C Briani, M Grandis, T Vigo, M Gobbi, E Ghiglione, M Carpo, ... Journal of the Peripheral Nervous System 12 (2), 102-107, 2007 | 118 | 2007 |
| Low sensitivity of bone scintigraphy in detecting Phe64Leu mutation-related transthyretin cardiac amyloidosis MB Musumeci, F Cappelli, D Russo, G Tini, M Canepa, A Milandri, ... Cardiovascular Imaging 13 (6), 1314-1321, 2020 | 102 | 2020 |
| Monitoring effectiveness and safety of Tafamidis in transthyretin amyloidosis in Italy: a longitudinal multicenter study in a non-endemic area A Cortese, G Vita, M Luigetti, M Russo, G Bisogni, M Sabatelli, ... Journal of neurology 263, 916-924, 2016 | 101 | 2016 |
| MYH7-related myopathies: clinical, histopathological and imaging findings in a cohort of Italian patients C Fiorillo, G Astrea, M Savarese, D Cassandrini, G Brisca, F Trucco, ... Orphanet journal of rare diseases 11, 1-14, 2016 | 89 | 2016 |
| Different cellular and molecular mechanisms for early and late-onset myelin protein zero mutations M Grandis, T Vigo, M Passalacqua, M Jain, S Scazzola, V La Padula, ... Human molecular genetics 17 (13), 1877-1889, 2008 | 81 | 2008 |
| HSPB1 and HSPB8 in inherited neuropathies: study of an Italian cohort of dHMN and CMT2 patients S Capponi, A Geroldi, P Fossa, M Grandis, P Ciotti, R Gulli, A Schenone, ... Journal of the Peripheral Nervous System 16 (4), 287-294, 2011 | 76 | 2011 |
| RFC1 expansions are a common cause of idiopathic sensory neuropathy R Currò, A Salvalaggio, S Tozza, C Gemelli, N Dominik, V Galassi Deforie, ... Brain 144 (5), 1542-1550, 2021 | 74 | 2021 |
| Inherited neuropathies A Schenone, L Nobbio, M Monti Bragadin, G Ursino, M Grandis Current treatment options in neurology 13, 160-179, 2011 | 67 | 2011 |
| Current therapy for Charcot-Marie-Tooth disease M Grandis, ME Shy Current treatment options in neurology 7 (1), 23-31, 2005 | 66 | 2005 |
| ATTRv amyloidosis Italian Registry: clinical and epidemiological data M Russo, L Obici, I Bartolomei, F Cappelli, M Luigetti, S Fenu, T Cavallaro, ... Amyloid 27 (4), 259-265, 2020 | 63 | 2020 |
| Outcome measures and rehabilitation treatment in patients affected by Charcot-Marie-Tooth neuropathy: a pilot study G Maggi, MM Bragadin, L Padua, E Fiorina, E Bellone, M Grandis, L Reni, ... American Journal of Physical Medicine & Rehabilitation 90 (8), 628-637, 2011 | 57 | 2011 |
| Nerve conduction velocity in CMT 1A: what else can we tell? F Manganelli, C Pisciotta, MM Reilly, S Tozza, A Schenone, GM Fabrizi, ... European journal of neurology 23 (10), 1566-1571, 2016 | 56 | 2016 |
| Major myelin protein gene (P0) mutation causes a novel form of axonal degeneration J Li, Y Bai, E Ianakova, M Grandis, F Uchwat, A Trostinskaia, ... Journal of Comparative Neurology 498 (2), 252-265, 2006 | 56 | 2006 |
| Mycophenolate mofetil in dysimmune neuropathies: a preliminary study L Benedetti, M Grandis, L Nobbio, A Beronio, E Ghiglione, M Manzino, ... Muscle & Nerve: Official Journal of the American Association of …, 2004 | 50 | 2004 |
| Impairment of PMP22 transgenic Schwann cells differentiation in culture: implications for Charcot-Marie-Tooth type 1A disease L Nobbio, T Vigo, M Abbruzzese, G Levi, C Brancolini, S Mantero, ... Neurobiology of disease 16 (1), 263-273, 2004 | 49 | 2004 |
